Home ETF List About

Portfolio Holdings Detail for ISIN IE00BMBKBZ46
Stock Name / FundiShares S&P 500 Health Care Sector UCITS ETF
IssuerBlackrock
Entity holding fund iShares V Public Limited Company
Entity Type
Entity LEI 549300QETNU1W5JY7Z94
ETF TickerIUHE.AS(EUR) CXE
ETF TickerIUHE(EUR) Euronext Amsterdam

Holdings detail for MRK

Stock NameMarks Electrical Group PLC
TickerMRK(GBX) LSE
TYPECommon Stock
CountryUK
ISINGB00BM8Q5G47
LEI2138007KN8TKPIXIQE92
TickerMRK(EUR) F

Show aggregate MRK holdings

News associated with MRK

Surprising Analyst 12-Month Target For FDL
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-22 08:04:45
IWD, JNJ, MCD, MRK: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 Value ETF (Symbol: IWD) where we have detected an approximate $565.9 million dollar inflow -- that's a 0.9% increase week over w - 2025-09-18 13:26:06
Daiichi Sankyo, Merck Say Raludotatug Deruxtecan Granted Breakthrough Therapy Designation
(RTTNews) - Daiichi Sankyo Company Limited (DSKYF) and Merck & Co Inc. (MRK) said on Monday that the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation for their raludotatug deruxtecan for the treatment of adults with platinum-resistant epithelia - 2025-09-15 08:43:59
Peter Lynch Detailed Fundamental Analysis - MRK
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-12 10:32:51
Guru Fundamental Report for MRK - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-11 10:33:21
Notable ETF Inflow Detected - VYM, JNJ, MRK, CME
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard High Dividend Yield ETF (Symbol: VYM) where we have detected an approximate $440.7 million dollar inflow -- that's a 0.7% increase week over - 2025-09-10 11:50:46
MRK Factor-Based Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-10 10:34:14
Daiichi Sankyo And Merck : Ifinatamab Deruxtecan Shows Promising Results In Phase 2 ES-SCLC Trial
(RTTNews) - Daiichi Sankyo (DSKYF, 4568.T) and Merck & Co Inc. (MRK) announced that Results from the IDeate-Lung01 phase 2 trial showed that ifinatamab deruxtecan (I-DXd) demonstrated clinically meaningful response rates in patients with previously treated extensive-stage small c - 2025-09-08 02:18:22
Peter Lynch Detailed Fundamental Analysis - MRK
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-05 10:33:56
Pre-Market Most Active for Sep 5, 2025 : OPEN, TSLL, SCAG, SQQQ, MRK, NVDA, KO, AVGO, SNAP, FIG, WMT, NIO
The NASDAQ 100 Pre-Market Indicator is up 147.96 to 23,780.97. The total Pre-Market volume is currently 100,628,631 shares traded.The following are the most active stocks for the pre-market session: Opendoor Technologies Inc (OPEN) is +0.27 at $6.23, with 12,819,663 shares trade - 2025-09-05 09:29:53
Guru Fundamental Report for MRK - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-04 10:32:25
MRK Factor-Based Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-03 10:34:47
Peter Lynch Detailed Fundamental Analysis - MRK
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-29 10:33:23
MRK's Strong Dividend History Helps it Reach 'Top Dividend Stock of the Dow'
Merck & Co Inc (Symbol: MRK) has been named as the ''Top Dividend Stock of the Dow'', according to Dividend Channel, which published its most recent ''DividendRank'' report. The report noted that among the components of the Dow Jones Industrial Average, MRK shares displayed b - 2025-08-28 08:50:04
MRK Factor-Based Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-27 10:34:49
MRK Quantitative Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-26 10:34:02
iShares MSCI ACWI ETF Experiences Big Outflow
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI ACWI ETF (Symbol: ACWI) where we have detected an approximate $429.5 million dollar outflow -- that's a 1.9% decrease week over week (f - 2025-08-25 13:36:45
Peter Lynch Detailed Fundamental Analysis - MRK
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-22 10:34:21
Dow Movers: WMT, MRK
In early trading on Thursday, shares of Merck topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.2%. Year to date, Merck has lost about 13.8% of its value. And the worst performing Dow component thus far on the day is Walmart, tr - 2025-08-21 11:27:42
MRK Factor-Based Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-20 10:34:00
After Hours Most Active for Aug 19, 2025 : CSX, INTC, MRK, NVDA, IBN, KO, FUN, PEP, CX, WMT, HTZ, QQQ
The NASDAQ 100 After Hours Indicator is down -1.71 to 23,383.06. The total After hours volume is currently 259,932,235 shares traded.The following are the most active stocks for the after hours session: CSX Corporation (CSX) is -0.04 at $36.48, with 11,794,785 shares traded. Ove - 2025-08-19 17:24:59
Daiichi Sankyo Announces Breakthrough Therapy Designation For Ifinatamab Deruxtecan
(RTTNews) - Daiichi Sankyo announced that Ifinatamab deruxtecan has been granted Breakthrough Therapy Designation by the FDA for the treatment of adult patients with extensive-stage small cell lung cancer with disease progression on or after platinum-based chemotherapy. The FDA g - 2025-08-18 08:36:51
The Zacks Analyst Blog Highlights Merck, Palo Alto Networks, Freeport-McMoRan and Espey
Analysts spotlight Merck, Palo Alto Networks, Freeport-McMoRan, and Espey as innovation, contract wins, and industry trends shape growth prospects. - 2025-08-15 12:44:00
Noteworthy ETF Outflows: SUSL, MCD, DIS, MRK
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares ESG MSCI USA Leaders ETF (Symbol: SUSL) where we have detected an approximate $84.6 million dollar outflow -- that's a 8.7% decrease week ov - 2025-08-15 11:49:25
Peter Lynch Detailed Fundamental Analysis - MRK
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-15 10:31:59
Top Analyst Reports for Merck, Palo Alto & Freeport
Merck leans on Keytruda growth and pipeline expansion, Palo Alto rides subscription security demand, and Freeport benefits from electrification-driven copper demand. - 2025-08-14 17:46:00
Stocks See Support As Bessent Calls for a Big Rate Cut
The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 15:15:33
MRK April 2026 Options Begin Trading
Investors in Merck & Co Inc (Symbol: MRK) saw new options become available today, for the April 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 246 days until expiration the newly available contra - 2025-08-14 14:30:24
Stocks See Support As Bessent Calls for a Big Rate Cut
The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 14:05:26
Stocks See Support As Bessent Calls for a Big Rate Cut
The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 12:17:47

iShares S&P 500 Health Care Sector UCITS ETF MRK holdings

DateNumber of MRK Shares HeldBase Market Value of MRK SharesLocal Market Value of MRK SharesChange in MRK Shares HeldChange in MRK Base ValueCurrent Price per MRK Share HeldPrevious Price per MRK Share Held
2025-11-11 (Tuesday)1,242,655USD 113,019,472MRK holding increased by 5219151USD 113,019,4720USD 5,219,151 USD 90.95 USD 86.75
2025-11-10 (Monday)1,242,655MRK holding increased by 13720USD 107,800,321MRK holding increased by 1767809USD 107,800,32113,720USD 1,767,809 USD 86.75 USD 86.28
2025-11-07 (Friday)1,228,935USD 106,032,512MRK holding increased by 614468USD 106,032,5120USD 614,468 USD 86.28 USD 85.78
2025-11-06 (Thursday)1,228,935MRK holding increased by 1372USD 105,418,044MRK holding increased by 1824002USD 105,418,0441,372USD 1,824,002 USD 85.78 USD 84.39
2025-11-05 (Wednesday)1,227,563MRK holding decreased by -1372USD 103,594,042MRK holding increased by 535553USD 103,594,042-1,372USD 535,553 USD 84.39 USD 83.86
2025-11-04 (Tuesday)1,228,935MRK holding increased by 1372USD 103,058,489MRK holding increased by 1796817USD 103,058,4891,372USD 1,796,817 USD 83.86 USD 82.49
2025-11-03 (Monday)1,227,563USD 101,261,672MRK holding decreased by -4284195USD 101,261,6720USD -4,284,195 USD 82.49 USD 85.98
2025-10-31 (Friday)1,227,563MRK holding increased by 6990USD 105,545,867MRK holding increased by 234829USD 105,545,8676,990USD 234,829 USD 85.98 USD 86.28
2025-10-30 (Thursday)1,220,573MRK holding decreased by -8388USD 105,311,038MRK holding decreased by -1092405USD 105,311,038-8,388USD -1,092,405 USD 86.28 USD 86.58
2025-10-29 (Wednesday)1,228,961MRK holding decreased by -2796USD 106,403,443MRK holding decreased by -796369USD 106,403,443-2,796USD -796,369 USD 86.58 USD 87.03
2025-10-28 (Tuesday)1,231,757MRK holding increased by 2655USD 107,199,812MRK holding decreased by -961164USD 107,199,8122,655USD -961,164 USD 87.03 USD 88
2025-10-27 (Monday)1,229,102MRK holding decreased by -2796USD 108,160,976MRK holding increased by 382220USD 108,160,976-2,796USD 382,220 USD 88 USD 87.49
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of MRK by Blackrock for IE00BMBKBZ46

Show aggregate share trades of MRK

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY13,72087.37085.800 85.957GBX 1,179,330 87.22
2025-11-06BUY1,37286.17084.350 84.532GBX 115,978 87.23
2025-11-05SELL-1,37285.38082.912 83.159GBX -114,093 87.24 Profit of 5,600 on sale
2025-11-04BUY1,37284.96082.035 82.328GBX 112,953 87.26
2025-10-31BUY6,99086.46084.560 84.750GBX 592,402 87.29
2025-10-30SELL-8,38887.30083.300 83.700GBX -702,076 87.29 Profit of 30,128 on sale
2025-10-29SELL-2,79687.84086.072 86.248GBX -241,150 87.30 Profit of 2,928 on sale
2025-10-28BUY2,65588.10586.930 87.048GBX 231,111 87.30
2025-10-27SELL-2,79688.29587.030 87.157GBX -243,690 87.29 Profit of 382 on sale
2025-10-22SELL-1,39888.79087.030 87.206GBX -121,914 87.29 Profit of 119 on sale
2025-10-17SELL-5,59284.89083.200 83.369GBX -466,199 87.31 Profit of 22,024 on sale
2025-10-16BUY6,99085.50083.600 83.790GBX 585,692 87.33
2025-10-15BUY9,78684.69083.610 83.718GBX 819,264 87.34
2025-10-14BUY1,39885.68084.150 84.303GBX 117,856 87.36
2025-10-03BUY2,74290.70088.100 88.360GBX 242,283 87.35
2025-10-02BUY1,37091.00088.220 88.498GBX 121,242 87.33
2025-10-01BUY7,99290.75085.190 85.746GBX 685,282 87.32
2025-09-24SELL-3,66380.11579.330 79.409GBX -290,873 87.53 Profit of 29,753 on sale
2025-09-18BUY1,377 81.530* 87.56
2025-09-11BUY1,377 85.150* 87.65
2025-09-10BUY1,376 84.030* 87.67
2025-08-20BUY2,750 84.660* 87.72
2025-08-19BUY1,375 84.930* 87.73
2025-08-18BUY6,88085.14584.080 84.187GBX 579,203 87.75
2025-08-15BUY24,06784.74083.360 83.498GBX 2,009,546 87.77
2025-08-14BUY8,24483.40081.600 81.780GBX 674,194 87.80
2025-08-13BUY5,49682.84080.200 80.464GBX 442,230 87.83
2025-07-30BUY1,39683.58081.520 81.726GBX 114,089 87.92
2025-07-17SELL-1,39682.66081.340 81.472GBX -113,735 88.23 Profit of 9,434 on sale
2025-07-15SELL-5,58484.36081.300 81.606GBX -455,688 88.31 Profit of 37,438 on sale
2025-07-14SELL-13,97084.30083.110 83.229GBX -1,162,709 88.34 Profit of 71,410 on sale
2025-07-09SELL-1,39784.48081.890 82.149GBX -114,762 88.43 Profit of 8,779 on sale
2025-07-07SELL-2,79481.54080.150 80.289GBX -224,327 88.53 Profit of 23,028 on sale
2025-07-02BUY1,39782.79081.894 81.983GBX 114,530 88.68
2025-06-24SELL-23,78381.46079.090 79.327GBX -1,886,634 89.01 Profit of 230,183 on sale
2025-06-23BUY1,39980.22078.990 79.113GBX 110,679 89.07
2025-06-20SELL-2,79879.92078.600 78.732GBX -220,292 89.14 Profit of 29,123 on sale
2025-06-18SELL-1,39980.31077.100 77.421GBX -108,312 89.28 Profit of 16,597 on sale
2025-06-17BUY16,78880.70078.190 78.441GBX 1,316,868 89.37
2025-06-13SELL-2,79882.44081.450 81.549GBX -228,174 89.49 Profit of 22,206 on sale
2025-06-11SELL-1,39981.68079.980 80.150GBX -112,130 89.61 Profit of 13,238 on sale
2025-06-10SELL-2,79881.88079.330 79.585GBX -222,679 89.68 Profit of 28,234 on sale
2025-06-09SELL-4,19780.41078.670 78.844GBX -330,908 89.76 Profit of 45,795 on sale
2025-05-21SELL-1,37578.10076.870 76.993GBX -105,865 91.14 Profit of 19,447 on sale
2025-05-20SELL-2,75079.18077.422 77.597GBX -213,393 91.25 Profit of 37,545 on sale
2025-05-15SELL-4,125 74.800* 91.65 Profit of 378,073 on sale
2025-05-14SELL-4,125 73.470* 91.82 Profit of 378,743 on sale
2025-05-13BUY1,375 76.630* 91.95
2025-05-09SELL-1,375 75.970* 92.21 Profit of 126,783 on sale
2025-05-08BUY2,750 77.650* 92.34
2025-05-01BUY2,74884.57583.170 83.310GBX 228,937 92.87
2025-04-24SELL-1,37579.97076.030 76.424GBX -105,083 93.36 Profit of 23,292 on sale
2025-04-23BUY4,12580.20078.240 78.436GBX 323,548 93.51
2025-04-15SELL-1,37579.96077.720 77.944GBX -107,173 94.54 Profit of 22,821 on sale
2025-04-10SELL-2,75081.12075.962 76.477GBX -210,313 95.08 Profit of 51,166 on sale
2025-04-08SELL-1,37583.27077.540 78.113GBX -107,405 95.42 Profit of 23,803 on sale
2025-04-07SELL-1,37583.21079.300 79.691GBX -109,575 95.59 Profit of 21,863 on sale
2025-04-04SELL-2,75086.26081.090 81.607GBX -224,419 95.76 Profit of 38,920 on sale
2025-04-02BUY1,375 86.600* 95.87
2025-04-01BUY12,375 87.120* 95.98
2025-03-31SELL-8,244 89.760* 96.05 Profit of 791,866 on sale
2025-03-28BUY1,374 89.230* 96.14
2025-03-26SELL-863 88.110* 96.35 Profit of 83,151 on sale
2025-03-21BUY14,156 93.110* 96.56
2025-03-20BUY5,476 94.730* 96.59
2025-03-17SELL-1,369 94.790* 96.67 Profit of 132,347 on sale
2025-03-12SELL-966 93.350* 96.78 Profit of 93,492 on sale
2025-03-07BUY1,367 94.650* 96.87
2025-02-28SELL-4,10192.35090.710 90.874GBX -372,674 97.14 Profit of 25,691 on sale
2025-02-25BUY13,67093.06090.440 90.702GBX 1,239,896 97.48
2025-02-20BUY9,56987.70085.900 86.080GBX 823,700 97.92
2025-02-19BUY4,10185.63082.850 83.128GBX 340,908 98.15
2025-02-18BUY2,73483.59081.040 81.295GBX 222,261 98.43
2025-02-13BUY6,83085.69084.310 84.448GBX 576,780 99.33
2025-02-04BUY5,46491.23087.330 87.720GBX 479,302 101.21
2025-01-31BUY1,366100.06098.580 98.728GBX 134,862 101.30
2025-01-29BUY1,36699.15097.390 97.566GBX 133,275 101.44
2025-01-27BUY2,73298.62095.990 96.253GBX 262,963 101.64
2025-01-24BUY1,36697.10095.410 95.579GBX 130,561 101.81
2025-01-02SELL-46,806100.35098.840 98.991GBX -4,633,373 102.04 Profit of 142,712 on sale
2024-12-10SELL-1,359103.770100.750 101.052GBX -137,330 102.07 Profit of 1,386 on sale
2024-12-09SELL-35,334105.070102.330 102.604GBX -3,625,410 102.02 Loss of -20,712 on sale
2024-12-03SELL-16,308102.450100.620 100.803GBX -1,643,895 101.95 Profit of 18,769 on sale
2024-12-02SELL-6,795101.850100.460 100.599GBX -683,570 102.00 Profit of 9,545 on sale
2024-11-29SELL-3,393103.040101.530 101.681GBX -345,004 102.02 Profit of 1,142 on sale
2024-11-22SELL-13,590101.79098.930 99.216GBX -1,348,345 102.11 Profit of 39,297 on sale
2024-11-21SELL-6,795100.48096.950 97.303GBX -661,174 102.22 Profit of 33,411 on sale
2024-11-20BUY10,87298.84096.660 96.878GBX 1,053,258 102.47
2024-11-18SELL-16,30897.29095.420 95.607GBX -1,559,159 103.17 Profit of 123,309 on sale
2024-11-11BUY12,231103.370100.460 100.751GBX 1,232,285 103.64
2024-11-08SELL-43,456103.230101.020 101.241GBX -4,399,529 103.69 Profit of 106,331 on sale
2024-11-07SELL-2,716101.690100.850 100.934GBX -274,137 103.88 Profit of 8,006 on sale
2024-11-01SELL-2,716102.720101.210 101.361GBX -275,296 104.93 Profit of 9,681 on sale
2024-10-31SELL-5,432103.23098.600 99.063GBX -538,110 105.25 Profit of 33,615 on sale
2024-10-30BUY1,358105.000102.900 103.110GBX 140,023 105.31
2024-10-29BUY8,148105.110103.700 103.841GBX 846,096 105.57
2024-10-28SELL-4,074105.000103.930 104.037GBX -423,847 105.84 Profit of 7,362 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MRK

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-191,053,2942,0243,869,11627.2%
2025-09-181,184,9228,0053,015,34039.3%
2025-09-171,616,76818,7303,647,85344.3%
2025-09-161,223,7119603,598,70934.0%
2025-09-151,814,7678,4204,295,96242.2%
2025-09-122,018,4637,5573,506,69457.6%
2025-09-111,493,7285,3993,180,82847.0%
2025-09-102,013,1025,3353,313,84760.7%
2025-09-091,075,1375,5052,373,81745.3%
2025-09-082,147,2042,4483,731,34357.5%
2025-09-051,440,1149,9482,983,29648.3%
2025-09-041,439,7261,1215,661,88725.4%
2025-09-031,849,1033,5534,699,60739.3%
2025-09-022,193,136115,1354,314,82650.8%
2025-08-291,545,05711,4203,841,71540.2%
2025-08-281,559,7666,1695,284,88829.5%
2025-08-271,383,4767,8383,737,50637.0%
2025-08-261,328,2351,2292,869,94446.3%
2025-08-252,177,2005,5783,771,31357.7%
2025-08-221,523,3527,4973,248,57546.9%
2025-08-212,449,66018,5405,416,96945.2%
2025-08-201,189,29116,6923,133,34538.0%
2025-08-191,722,6512,3313,737,68946.1%
2025-08-181,150,9372,8222,604,34444.2%
2025-08-151,795,3941,6733,415,80852.6%
2025-08-142,198,5622,2724,496,39848.9%
2025-08-131,885,48019,5373,953,04547.7%
2025-08-121,593,84410,3603,185,66750.0%
2025-08-11990,4053,6052,886,69034.3%
2025-08-081,224,37811,1872,672,27945.8%
2025-08-071,718,6615,3564,504,85038.2%
2025-08-062,028,9271,8824,007,25250.6%
2025-08-051,573,6816,0493,579,53444.0%
2025-08-041,568,9759443,301,80147.5%
2025-08-011,718,70113,8534,079,64242.1%
2025-07-313,367,7552,6646,082,64455.4%
2025-07-302,253,4585,8784,162,63654.1%
2025-07-295,939,07236,24911,111,79553.4%
2025-07-282,243,2356,7394,563,91349.2%
2025-07-251,302,4376,9002,889,20745.1%
2025-07-241,156,3972,5702,732,35142.3%
2025-07-231,879,40020,2804,001,02547.0%
2025-07-221,628,7541,7733,592,84745.3%
2025-07-211,900,56312,5715,188,43236.6%
2025-07-181,536,7621,2463,463,05944.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.